-
-
Studies taken from the American College of Cardiology Annual Meeting held in New Orleans.
-
The International Long QT Syndrome Registry enrolls patients and family members with LQTS in a longitudinal observational study.
-
Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, has been in development by Pfizer for nearly 15 years.
-
-
-
Deep venous thrombosis (DVT) and its sequela, pulmonary embolism (PE), remain significant clinical challenges and the leading causes of preventable in-hospital mortality in the United States.
-
A Nashville, TN, hospice used well-analyzed results from staff satisfaction surveys and family satisfaction surveys to improve the quality of care, as well as staff satisfaction.
-
Are internal defibrillators and pacemakers biofixtures, like artificial hearts, that should not be deactivated when a patient is dying?
-
At the end of life, there often comes a point when there's nothing more, clinically, that can be done. That's when the music starts for some patients.
